| Literature DB >> 31427992 |
Thomas Gronwald1, Olaf Hoos2, Kuno Hottenrott3.
Abstract
AIM: Measurements of Non-linear dynamics of heart rate variability (HRV) provide new possibilities to monitor cardiac autonomic activity during exercise under different environmental conditions. Using detrended fluctuation analysis (DFA) technique to assess correlation properties of heart rate (HR) dynamics, the present study examines the influence of normobaric hypoxic conditions (HC) in comparison to normoxic conditions (NC) during a constant workload exercise.Entities:
Keywords: autonomic nervous system; detrended fluctuation analysis; endurance exercise; heart rate variability; hypoxia; voluntary exhaustion
Year: 2019 PMID: 31427992 PMCID: PMC6688521 DOI: 10.3389/fphys.2019.00999
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.566
FIGURE 1Flow chart of the constant workload until voluntary exhaustion during normoxic and normobaric hypoxic condition. IAT: individual anaerobic threshold; WU (1): Warm-Up at 100 W; WU (2): Warm-Up at 150 W; CD: Cool-Down at 100 W.
Heart rate, oxygen saturation, lactate, rating of perceived exertion and HRV measures (Mean ± SD) during resting state and all cycling conditions during normoxia (NC) and normobaric hypoxia (HC).
| HR [1/min] | NC | 72.2 ± 5.7 | 108,4* ± 10.1 | 120,5* ± 13.6 | 147,2* ± 11.5 | 155,0* ± 10.9 | 157,3* ± 11.0 | 159,1 ± 10.3 | 160,3 ± 9.6 | 161,4 ± 9.3 | 163,9* ± 9.4 | 169,0* ± 8.5 | 174,7* ± 7.9 | 180,5*¥± 9.0 | 126,9*§ ± 11.0 |
| HC | 69.3 ± 8.8 | 111.8* ± 10.0 | 127.2* ± 12.0 | 145.9* ± 9.9 | 159.3* ± 8.7 | 165.3* ± 7.0 | 167.6# ± 6.4 | 169.1# ± 6.3 | 170.6# ± 6.2 | 172.3*# ± 6.0 | 173.6* ± 6.0 | 175.1* ± 6.6 | 176.8¥± 7.6 | 127.3*§ ± 12.0 | |
| ANOVA | 10–100% – Condition: F = 3.348, | ||||||||||||||
| SpO2 [%] | NC | 98.0 ± 0.5 | 97.1* ± 0.8 | 97.1 ± 0.6 | 96.0 ± 1.1 | 95.8 ± 1.3 | 96.1 ± 1.0 | 96.0 ± 0.7 | 95.7 ± 0.8 | 95.8 ± 0.8 | 95.9 ± 0.8 | 95.9 ± 0.8 | 95.5 ± 1.1 | 95.9 ± 1.1 | 97.7*§ ± 0.5 |
| HC | 92.4# ± 2.7 | 86.6*# ± 3.9 | 85.2# ± 2.7 | 84.5# ± 2.7 | 84.0# ± 2.8 | 83.7# ± 2.7 | 83.4# ± 2.3 | 83.3# ± 2.1 | 83.3# ± 2.1 | 83.4# ± 2.3 | 83.4# ± 2.3 | 83.1# ± 2.1 | 82.7#¥± 2.2 | 91.1*§ # ± 2.5 | |
| ANOVA | 10–100% – Condition: | ||||||||||||||
| La [mmol/l] | NC | 1.03 ± 0.27 | 0.72* ± 0.30 | 0.94 ± 0.62 | 2.19* ± 0.92 | 2.65 ± 1.28 | 2.70 ± 1.63 | 2.67 ± 1.90 | 2.69 ± 2.07 | 2.78 ± 2.27 | 3.11 ± 2.41 | 3.72 ± 2.53 | 4.75 ± 2.44 | 6.89¥± 2.09 | 3.30*§ ± 1.59 |
| HC | 0.73 ± 0.21 | 0.65 ± 0.15 | 0.86* ± 0.33 | 2.94*# ± 0.39 | 4.55*# ± 0.58 | 5.48*# ± 0.79 | 5.98*# ± 0.94 | 6.31# ± 1.26 | 6.68# ± 1.73 | 7.13# ± 2.06 | 7.49# ± 2.09 | 7.76# ± 1.97 | 8.14¥± 1.78 | 3.61*§ ± 0.96 | |
| ANOVA | 10–100% – Condition: | ||||||||||||||
| RPE [6-20] | NC | – | 7.2 ± 1.6 | 8.8* ± 1.9 | 13.0* ± 1.3 | 14.1* ± 1.0 | 14.2 ± 1.2 | 14.5 ± 1.2 | 15.0 ± 1.1 | 15.1 ± 1.4 | 15.5 ± 1.5 | 16.5 ± 1.2 | 17.3 ± 1.5 | 19.7¥± 0.7 | 7.9* ± 2.0 |
| HC | – | 7.2 ± 1.3 | 9.4* ± 1.8 | 12.4* ± 1.4 | 14.4* ± 1.2 | 15.2 ± 1.3 | 15.8 ± 1.3 | 16.3# ± 1.1 | 16.8# ± 1.2 | 17.5# ± 1.4 | 18.1# ± 1.4 | 18.7# ± 1.1 | 19.6¥± 0.7 | 7.9* ± 1.5 | |
| ANOVA | 10–100% – Condition: | ||||||||||||||
| meanRR [ms] | NC | 842 ± 66 | 558* ± 49 | 503* ± 52 | 411* ± 34 | 388* ± 28 | 383 ± 28 | 378 ± 25 | 376 ± 22 | 373 ± 21 | 367* ± 21 | 356* ± 18 | 344* ± 16 | 333*¥± 17 | 476*§ ± 41 |
| HC | 884 ± 99 | 538* ± 53 | 471* ± 48 | 417* ± 32 | 379* ± 22 | 362* ± 15 | 358# ± 14 | 356# ± 13 | 352# ± 13 | 349*# ± 12 | 346* ± 12 | 343* ± 13 | 340¥± 15 | 474*§ ± 46 | |
| ANOVA | 10–100% – Condition: | ||||||||||||||
| SDNN [ms] | NC | 66.5 ± 17.5 | 8.7* ± 3.0 | 5.7* ± 1.9 | 2.6* ± 0.7 | 2.1 ± 0.4 | 2.3 ± 0.3 | 2.1 ± 0.3 | 2.0 ± 0.3 | 2.0 ± 0.3 | 1.9 ± 0.4 | 1.9 ± 0.4 | 2.0 ± 0.5 | 2.1 ± 0.5 | 3.6*§ ± 1.2 |
| HC | 82.3 ± 21.9 | 6.8* ± 1.8 | 4.2* ± 1.5 | 2.9 ± 0.7 | 2.1 ± 0.5 | 1.9 ± 0.4 | 1.9 ± 0.4 | 2.0 ± 0.5 | 2.1 ± 0.5 | 2.1 ± 0.4 | 2.1 ± 0.5 | 2.2 ± 0.6 | 2.3¥± 0.6 | 3.3*§ ± 0.7 | |
| ANOVA | 10–100% – Condition: F = 0.340, | ||||||||||||||
| DFA-alpha1 [] | NC | 1.35 ± 0.13 | 1.49* ± 0.16 | 1.27* ± 0.25 | 0.79* ± 0.14 | 0.66 ± 0.14 | 0.62 ± 0.18 | 0.54 ± 0.16 | 0.50 ± 0.13 | 0.51 ± 0.11 | 0.47 ± 0.12 | 0.38 ± 0.12 | 0.31 ± 0.14 | 0.31¥± 0.11 | 1.18*§ ± 0.28 |
| HC | 1.26 ± 0.10 | 1.44* ± 0.18 | 1.11* ± 0.25 | 0.77* ± 0.16 | 0.53*# ± 0.13 | 0.41# ± 0.08 | 0.38# ± 0.08 | 0.39# ± 0.12 | 0.36# ± 0.14 | 0.34 ± 0.18 | 0.32 ± 0.16 | 0.32 ± 0.15 | 0.33¥± 0.12 | 0.99*§ ± 0.20 | |
| ANOVA | 10–100% – Condition: | ||||||||||||||
FIGURE 2Heart rate (A), blood lactate concentration (B) during resting state and all cycling conditions during normoxia (NC, black color) and normobaric hypoxia (HC, gray color). WU (1): Warm-Up at 100W; WU (2): Warm-Up at 150W; 10–100%: Percentage of continuous workload; CD: Cool-Down at 100W. *Significant compared to preceding measurement; §Significant change WU (1) vs. CD at 100W; ¥Significant change 10% vs. 100%; #Significant change NC vs. HC (p ≤ 0.05).
FIGURE 4Short-term scaling exponent (DFA-alpha1) during resting state and all cycling conditions during normoxia (NC, black color) and normobaric hypoxia (HC, gray color). WU (1): Warm-Up at 100 W; WU (2): Warm-Up at 150 W; 10–100%: Percentage of continuous workload; CD: Cool-Down at 100 W. *Significant compared to preceding measurement; §Significant change WU (1) vs. CD at 100 W; ¥Significant change 10% vs. 100%; #Significant change NC vs. HC (p ≤ 0.05).